CDM RCT: Computerized Contraceptive Decision Aid
Study Details
Study Description
Brief Summary
The purpose of this study is to conduct a randomized clinical trial of a web-based contraceptive decision aid compared to routine contraceptive counseling to evaluate the effect of the contraceptive decision aid on the contraceptive method selected by the participant.
The investigators primary hypothesis is that women utilizing a computerized Contraceptive Decision Aid (CDA) will be more likely to choose highly effective contraception than women who undergo standard clinical contraceptive counseling.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Our primary specific aim is to test the CDA by conducting a randomized clinical trial comparing the CDA to routine contraceptive counseling. Our primary outcome of interest will be selection of highly effective contraception including the intrauterine device (IUD), the implant, and injectable contraception compared to all other reversible contraceptive methods.
We will also complete the following secondary specific aims:
-
We will use the validated Decisional Conflict Scale to measure decisional conflict pre- and post-intervention and compare the change in decisional conflict score in women randomized to the CDA to women undergoing routine counseling.
-
We will also evaluate satisfaction with contraceptive counseling and contraceptive continuation and satisfaction at 3 and 6 months.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: CDM Tool participants will be randomized to completing the CDM tool |
Other: CDM Tool
Participants will be required to complete the CDM tool and receive a tailored print out of their contraceptive options based on survey answers
|
No Intervention: Control Participants will fill out a computer survey similar to CDM tool without the decisive factors and computer print out |
Outcome Measures
Primary Outcome Measures
- Decisional Conflict Scale Score [Pre-Visit and Post-Visit (same day)]
Pre-Visit, Post-Visit and change in Decisional Conflict Scale (DCS) Score between Post-Visit (immediately following visit) and Pre-Visit (immediately prior to visit). The Decisional Conflict Scale scores range from 0 to 100; 0 represents no decisional conflict and 100 represents high decisional conflict.
Secondary Outcome Measures
- Contraceptive Method Chosen [Post-visit (immediately after visit)]
Contraceptive method chosen at end of visit with healthcare provider as reported on the post-visit survey
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Ages 18-45 years old
-
At risk for unintended pregnancy and seeking reversible contraception at Center of Advanced Medicine or Washington University Resident's Clinic
-
Willing and able to complete Contraceptive Decision Making tool
-
English speaking
Exclusion Criteria:
-
Have had a hysterectomy, bilateral oophorectomy, have undergone female sterilization
-
Unable to give informed consent secondary to language barrier or cognitive limitation
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Washington University School of Medicine
- Society of Family Planning
Investigators
- Principal Investigator: Tessa E Madden, MD, MPH, Washington University School of Medicine
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- SFP5-8 -201112047
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | CDM Tool | Control |
---|---|---|
Arm/Group Description | participants will be randomized to completing the CDM tool CDM Tool: Participants will be required to complete the CDM tool and receive a tailored print out of their contraceptive options based on survey answers | Participants will fill out a computer survey similar to CDM tool without the decisive factors and computer print out |
Period Title: Overall Study | ||
STARTED | 167 | 86 |
Baseline Survey | 166 | 85 |
COMPLETED | 161 | 80 |
NOT COMPLETED | 6 | 6 |
Baseline Characteristics
Arm/Group Title | CDM Tool | Control | Total |
---|---|---|---|
Arm/Group Description | participants will be randomized to completing the CDM tool CDM Tool: Participants will be required to complete the CDM tool and receive a tailored print out of their contraceptive options based on survey answers | Participants will fill out a computer survey similar to CDM tool without the decisive factors and computer print out | Total of all reporting groups |
Overall Participants | 166 | 85 | 251 |
Age (years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [years] |
28.5
(6.2)
|
28.4
(6.2)
|
28.5
(6.2)
|
Sex: Female, Male (Count of Participants) | |||
Female |
166
100%
|
85
100%
|
251
100%
|
Male |
0
0%
|
0
0%
|
0
0%
|
Race/Ethnicity, Customized (Count of Participants) | |||
Black |
62
37.3%
|
23
27.1%
|
85
33.9%
|
White |
84
50.6%
|
55
64.7%
|
139
55.4%
|
Other |
20
12%
|
7
8.2%
|
27
10.8%
|
Region of Enrollment (participants) [Number] | |||
United States |
166
100%
|
85
100%
|
251
100%
|
Outcome Measures
Title | Decisional Conflict Scale Score |
---|---|
Description | Pre-Visit, Post-Visit and change in Decisional Conflict Scale (DCS) Score between Post-Visit (immediately following visit) and Pre-Visit (immediately prior to visit). The Decisional Conflict Scale scores range from 0 to 100; 0 represents no decisional conflict and 100 represents high decisional conflict. |
Time Frame | Pre-Visit and Post-Visit (same day) |
Outcome Measure Data
Analysis Population Description |
---|
8 subjects did not complete the post-visit survey, so a post-visit DCS score and change in DCS score could not be calculated |
Arm/Group Title | CDM Tool | Control |
---|---|---|
Arm/Group Description | participants will be randomized to completing the CDM tool CDM Tool: Participants will be required to complete the CDM tool and receive a tailored print out of their contraceptive options based on survey answers | Participants will fill out a computer survey similar to CDM tool without the decisive factors and computer print out |
Measure Participants | 166 | 83 |
Pre-Visit Score |
15
|
10
|
Post-Visit Score |
0
|
0
|
Change in Score |
-10
|
-10
|
Title | Contraceptive Method Chosen |
---|---|
Description | Contraceptive method chosen at end of visit with healthcare provider as reported on the post-visit survey |
Time Frame | Post-visit (immediately after visit) |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | CDM Tool | Control |
---|---|---|
Arm/Group Description | participants will be randomized to completing the CDM tool CDM Tool: Participants will be required to complete the CDM tool and receive a tailored print out of their contraceptive options based on survey answers | Participants will fill out a computer survey similar to CDM tool without the decisive factors and computer print out |
Measure Participants | 161 | 80 |
LNG-IUS |
45
27.1%
|
21
24.7%
|
Copper IUD |
9
5.4%
|
3
3.5%
|
Implant |
9
5.4%
|
6
7.1%
|
DMPA |
19
11.4%
|
4
4.7%
|
Pills |
57
34.3%
|
29
34.1%
|
Contraceptive patch |
1
0.6%
|
0
0%
|
Vaginal ring |
8
4.8%
|
5
5.9%
|
Sterilization |
0
0%
|
3
3.5%
|
Condoms |
7
4.2%
|
4
4.7%
|
Other |
1
0.6%
|
3
3.5%
|
No method/undecided |
5
3%
|
2
2.4%
|
Adverse Events
Time Frame | ||||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | CDM Tool | Control | ||
Arm/Group Description | participants will be randomized to completing the CDM tool CDM Tool: Participants will be required to complete the CDM tool and receive a tailored print out of their contraceptive options based on survey answers | Participants will fill out a computer survey similar to CDM tool without the decisive factors and computer print out | ||
All Cause Mortality |
||||
CDM Tool | Control | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/167 (0%) | 0/86 (0%) | ||
Serious Adverse Events |
||||
CDM Tool | Control | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/167 (0%) | 0/86 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
CDM Tool | Control | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/167 (0%) | 0/86 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr. Tessa Madden, MD, MPH |
---|---|
Organization | Washington University in St. Louis |
Phone | 314-747-6495 |
maddent@wudosis.wustl.edu |
- SFP5-8 -201112047